VRCA
Verrica Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$104.10M
P/E Ratio
—
EPS
$-1.10
Beta
1.55
52W High
$9.82
52W Low
$3.28
50-Day MA
$6.11
200-Day MA
$5.91
Dividend Yield
—
Profit Margin
-48.00%
Forward P/E
—
PEG Ratio
—
About Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania.
Fundamentals
| Revenue (TTM) | $37.16M |
| Gross Profit (TTM) | $22.84M |
| EBITDA | $-13.06M |
| Operating Margin | -193.40% |
| Return on Equity | -240.40% |
| Return on Assets | -20.90% |
| Revenue/Share (TTM) | $2.73 |
| Book Value | $1.44 |
| Price-to-Book | 6.48 |
| Price-to-Sales (TTM) | 2.80 |
| EV/Revenue | 2.286 |
| EV/EBITDA | -11.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 46.10% |
| Shares Outstanding | $17.18M |
| Float | $7.90M |
| % Insiders | 48.69% |
| % Institutions | 27.87% |
Historical Volatility
HV 10-Day
88.12%
HV 20-Day
103.37%
HV 30-Day
93.27%
HV 60-Day
92.31%
HV Rank
57.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($16.43 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026